QQQ   358.21 (-1.74%)
AAPL   174.03 (-0.83%)
MSFT   320.26 (-0.16%)
META   296.61 (-1.02%)
GOOGL   130.60 (-2.35%)
AMZN   129.52 (-4.26%)
TSLA   256.90 (-2.17%)
NVDA   411.32 (-2.62%)
NIO   8.49 (-3.74%)
BABA   84.13 (-1.88%)
AMD   96.13 (-4.20%)
T   15.30 (-1.61%)
F   12.20 (-1.29%)
MU   68.04 (-2.35%)
CGC   0.77 (-11.47%)
GE   113.08 (-1.54%)
DIS   82.79 (+0.28%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.75 (-3.47%)
NFLX   383.71 (-0.67%)
QQQ   358.21 (-1.74%)
AAPL   174.03 (-0.83%)
MSFT   320.26 (-0.16%)
META   296.61 (-1.02%)
GOOGL   130.60 (-2.35%)
AMZN   129.52 (-4.26%)
TSLA   256.90 (-2.17%)
NVDA   411.32 (-2.62%)
NIO   8.49 (-3.74%)
BABA   84.13 (-1.88%)
AMD   96.13 (-4.20%)
T   15.30 (-1.61%)
F   12.20 (-1.29%)
MU   68.04 (-2.35%)
CGC   0.77 (-11.47%)
GE   113.08 (-1.54%)
DIS   82.79 (+0.28%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.75 (-3.47%)
NFLX   383.71 (-0.67%)
QQQ   358.21 (-1.74%)
AAPL   174.03 (-0.83%)
MSFT   320.26 (-0.16%)
META   296.61 (-1.02%)
GOOGL   130.60 (-2.35%)
AMZN   129.52 (-4.26%)
TSLA   256.90 (-2.17%)
NVDA   411.32 (-2.62%)
NIO   8.49 (-3.74%)
BABA   84.13 (-1.88%)
AMD   96.13 (-4.20%)
T   15.30 (-1.61%)
F   12.20 (-1.29%)
MU   68.04 (-2.35%)
CGC   0.77 (-11.47%)
GE   113.08 (-1.54%)
DIS   82.79 (+0.28%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.75 (-3.47%)
NFLX   383.71 (-0.67%)
QQQ   358.21 (-1.74%)
AAPL   174.03 (-0.83%)
MSFT   320.26 (-0.16%)
META   296.61 (-1.02%)
GOOGL   130.60 (-2.35%)
AMZN   129.52 (-4.26%)
TSLA   256.90 (-2.17%)
NVDA   411.32 (-2.62%)
NIO   8.49 (-3.74%)
BABA   84.13 (-1.88%)
AMD   96.13 (-4.20%)
T   15.30 (-1.61%)
F   12.20 (-1.29%)
MU   68.04 (-2.35%)
CGC   0.77 (-11.47%)
GE   113.08 (-1.54%)
DIS   82.79 (+0.28%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.75 (-3.47%)
NFLX   383.71 (-0.67%)
NYSE:EW

Edwards Lifesciences (EW) Price Target & Analyst Ratings

$70.16
-1.79 (-2.49%)
(As of 03:52 PM ET)
Compare
Today's Range
$70.04
▼
$71.89
50-Day Range
$71.95
▼
$93.38
52-Week Range
$67.13
▼
$94.87
Volume
2.23 million shs
Average Volume
3.16 million shs
Market Capitalization
$42.65 billion
P/E Ratio
31.04
Dividend Yield
N/A
Price Target
$92.42
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Edwards Lifesciences Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 18 Analyst Ratings

Consensus Analyst Price Target

$92.42
31.73% Upside
High Prediction$110.00
Average Prediction$92.42
Low Prediction$66.00
TypeCurrent
9/21/22 to 9/21/23		1 Month Ago
8/22/22 to 8/22/23		3 Months Ago
6/23/22 to 6/23/23		1 Year Ago
9/21/21 to 9/21/22
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
8 Buy rating(s)
7 Buy rating(s)
17 Buy rating(s)
Hold
9 Hold rating(s)
9 Hold rating(s)
9 Hold rating(s)
2 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$92.42$92.68$90.94$126.95
Predicted Upside31.73% Upside11.90% Upside13.17% Upside15.73% Upside
Get Edwards Lifesciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter.


EW Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EW Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Edwards Lifesciences Stock vs. The Competition

TypeEdwards LifesciencesMedical CompaniesS&P 500
Consensus Rating Score
2.39
2.65
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside31.90% Upside1,485.01% Upside696.29% Upside
News Sentiment RatingPositive News
Neutral News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/8/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetNeutral ➝ Neutral$88.00 ➝ $83.00+9.05%
8/17/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOutperform ➝ Outperform$96.00+23.06%
7/25/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy$103.00 ➝ $107.00+17.07%
7/19/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$101.00 ➝ $105.00+14.14%
7/18/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOutperform$107.00+16.32%
7/17/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$95.00 ➝ $102.00+9.23%
7/14/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOverweight ➝ Overweight$102.00+10.01%
7/10/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$101.00 ➝ $110.00+21.87%
6/27/202358.com
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingReiterates
4/28/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$94.00 ➝ $102.00+17.62%
4/27/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$78.00 ➝ $90.00+6.82%
4/24/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$75.00 ➝ $87.00+0.53%
3/28/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageNeutral$84.00+4.36%
2/6/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeOutperform ➝ Market Perform
2/1/2023Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetHold$68.00 ➝ $76.00-4.50%
1/31/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeOutperform ➝ Underperform$95.00 ➝ $66.00-13.23%
12/1/2022Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeOutperform ➝ Market Perform
11/3/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetNeutral$97.00 ➝ $73.00+6.26%
10/28/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$125.00 ➝ $100.00+38.85%
10/28/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$113.00 ➝ $83.00-3.82%
10/28/2022Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeOutperform ➝ Market Perform
(Data available from 9/21/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












EW Price Target - Frequently Asked Questions

What is Edwards Lifesciences's consensus rating and price target?

According to the issued ratings of 18 analysts in the last year, the consensus rating for Edwards Lifesciences stock is Hold based on the current 1 sell rating, 9 hold ratings and 8 buy ratings for EW. The average twelve-month price prediction for Edwards Lifesciences is $92.42 with a high price target of $110.00 and a low price target of $66.00. Learn more on EW's analyst rating history.

Do Wall Street analysts like Edwards Lifesciences more than its competitors?

Analysts like Edwards Lifesciences less than other Medical companies. The consensus rating for Edwards Lifesciences is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how EW compares to other companies.

Does Edwards Lifesciences's stock price have much upside?

According to analysts, Edwards Lifesciences's stock has a predicted upside of 12.28% based on their 12-month price targets.

What analysts cover Edwards Lifesciences?

Edwards Lifesciences has been rated by 58.com, Citigroup, Jefferies Financial Group, Mizuho, Morgan Stanley, Piper Sandler, Robert W. Baird, Royal Bank of Canada, and Truist Financial in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NYSE:EW) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -